An experimental drug could offer hope for restoring damaged brain cells in Parkinson’s patients, scientists said on Wednesday, although they cautioned that a clinical trial was not able to prove the treatment slowed or halted the neurodegenerative disease.
Researchers from Amen Clinics, Google, Johns Hopkins University, UCLA, and UC San Francisco studied 62,454 brain scans of more than 30,000 people to study brain aging.
Brain scans obtained during psychological stress might someday help doctors identify people who are at higher risk for heart disease, a new study suggests.
Brain scans of 23 Brazilian infants with the birth defect microcephaly showed widespread and severe abnormalities suggesting that Zika may invade fetal nerve cells and disrupt brain development. The […]
Scientists studying people with depression say brain scans could be used to predict who is most likely to relapse, an approach that could help doctors make better decisions about who […]